<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2023-06-01</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001860742</issuerCik>
        <issuerName>Bausch &amp; Lomb Corp</issuerName>
        <issuerTradingSymbol>BLCO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001980767</rptOwnerCik>
            <rptOwnerName>Bonnefoy Luc</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BAUSCH + LOMB CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>520 APPLEWOOD CRESCENT</rptOwnerStreet2>
            <rptOwnerCity>VAUGHAN</rptOwnerCity>
            <rptOwnerState>A6</rptOwnerState>
            <rptOwnerZipCode>L4K 4B4</rptOwnerZipCode>
            <rptOwnerStateDescription>ONTARIO, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>President,Surgical</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Shares, No Par Value</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>39368</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Options (right to purchase)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>18.00</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F5"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>83956</value>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Options (right to purchase)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>17.96</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F5"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>19676</value>
                    <footnoteId id="F4"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Reflects (i) an award of  21,222 restricted stock units (&quot;RSUs&quot;) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the &quot;Plan&quot;) granted on May 5, 2022 which is generally scheduled to vest 50% on the second anniversary of the grant date and 50% on the third anniversary of the date of grant or, if later, the earlier of Bausch + Lomb Corporation's (the &quot;Issuer&quot;) full separation from Bausch Health Companies, Inc. (&quot;BHC&quot;) or a change in control of the Issuer, (ii) an award of 12,000 RSUs under the Plan granted on August 2, 2022 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant and (iii) an award of 6,146 RSUs under the Plan granted on March 1, 2023 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant, in each case subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.</footnote>
        <footnote id="F2">(continued from footnote 1) Vested RSUs are settled in common shares, no par value (&quot;Common Shares&quot;), of the Issuer.</footnote>
        <footnote id="F3">Reflects an award of stock options to purchase Common Shares granted under the Plan on May 5, 2022. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date or, if later, upon the full separation from BHC or a change in control of the Issuer, subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.</footnote>
        <footnote id="F4">Reflects an award of stock options to purchase Common Shares granted under the Plan on March 1, 2023. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.</footnote>
        <footnote id="F5">The stock options will expire on the tenth anniversary of the grant date.</footnote>
    </footnotes>

    <remarks>Exhibit List: 24.1 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Debra E. Levin, attorney-in-fact</signatureName>
        <signatureDate>2023-06-12</signatureDate>
    </ownerSignature>
</ownershipDocument>
